***Background.*** Universal pneumococcal vaccination (UPV) in Argentina began in January 2012 using a 2 + 1 schedule using PCV13; vaccine coverage rate reached 50% in 2012, 75% in 2013. The objective was to evaluate the PCV13 impact 2 years after implementation.

***Methods.*** Multicenter (5 hospitals), prospective study. Hospitalized children (CH) \< 60 months with confirmed Invasive Pneumococal Disease (IPD) and/or consolidated pneumonia (CP) (WHO criteria) during 5 years (prevaccine period: 2009-2011 and post-vaccine period: 2012-2013) were included. Patients (pts) with CP or empyema (E) confirmed by any other agent than *S.pneumoniae* were excluded. Demographic and clinical data were recorded.

***Results.*** Pts included 1528; 1194(78%) CP, of 51/1120(4,5%) defined as Pneumococal-CP (P-CP); E:249(16.3%), 84/234(35.9%) of them confirmed as Pneumococal-E (PE) by culture; Meningitis 38(2,5%); other IPD:51(3,3%), including bacteremia, peritonitis, arthritis. The coverage rate in 2012 was 50% and 75% in 2013.

The decrease of IPD, CP and Pneumococcal Pulmonary Disease (PPD) (defined as P-CP + PE), after vaccination was:

  Period      Average of Admissions   Global IPD   CP                   PPD (P-CP + PE)                                  
  ----------- ----------------------- ------------ -------------------- ----------------- -------------------- --------- -----------------
  2009-2011   34,038                  56           16,5 (12,0 - 20,9)   300               88,1 (78,1 - 98,2)   37        10,9 (7,2-14,5)
  2012-2013   32,952                  28           8,5 (5,2 - 11,8)     147               44,6 (37,5 -52)      12,5      3,9 (1,6 - 6,2)
  Decrease                            -50%                              -51,00%                                -67,80%   
  *p*                                 0,003                             \<0,0001                               0,001     

\* Rate/10,000 admissions

The number of admission decreased 738 (-65.1%) and admission to ICU also was reduced 45(-38.8%); in addition the decrease of number of invasive procedures avoided was: central line 30 (-37%), thoracoscopy: 20 (-83%), pleural drainage 82(-59.4%), pleural decortication 22(-48.9%); the average days of antibiotic use was reduced in 1154 (-55.08%) after vaccination program implementation

2\. Hospitalizations by IPD and/or CP decreased 65.1% and requirement of ICU 38.8% after 2 years of UPV using PCV13 in our setting.

***Conclusion.*** A rapid and statistically significant decrease of IPD, CP and PPD was observed after 2 years of UVP in Argentina with a non-high coverage rate.
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